One-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study
The Lancet Sep 01, 2021
Huang L, Yao Q, Gu X, et al. - During 1-year follow-up of COVID-19 survivors, most reported a good physical and functional recovery, and had returned to their original work and life. Relative to the control population, COVID-19 survivors still had lower health status at 12 months.
An ambidirectional cohort study of COVID-19 survivors.
Survivors were administered questionnaires on symptoms and health-related quality of life (HRQoL), and underwent a physical examination, a 6-min walking test, and laboratory tests, at 6-month and 12-month follow-up visit.
Both visits were completed by 1,276 COVID-19 survivors; median age 59·0 years (IQR 49·0–67·0) and 53% men.
There was a decrease in the proportion of patients with at least one sequelae symptom from 68% (831/1227) at 6 months to 49% (620/1272) at 12 months.
A slight increase in the proportion of patients with dyspnoea and patients with anxiety or depression appeared.
Women had odd ratios of 1·43, 2·00, and 2·97 for fatigue or muscle weakness, anxiety or depression, and diffusion impairment, respectively, when compared with men.
More problems with mobility, pain or discomfort, and anxiety or depression, and greater prevalence of symptoms were recorded among matched COVID-19 survivors vs controls at 12 months.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries